652-P: Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a U.S. Commercially Insured and Medicare Advantage Population
Year: 2021
Type: article
Study design: Observational Study
Source: Diabetes
DOI: 10.2337/db21-652-p
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3175268624
